UPDATE: German Companies Could Offer Capital Injection to Deutsche Bank (DB) - Handelsblatt
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
(Updated - October 6, 2016 1:06 PM EDT)
CEOs of several German blue-chips companies have discussed the state of Deutsche Bank (NYSE: DB) and are prepared to offer a capital injection if needed to rescue it from a potentially crippling penalty in the U.S., according to Handelsblatt sources.
The participating companies would purchase Deutsche Bank stock to help shore up the bank's reserves. The injection would be in the low, single-digit billion euro range, the report said.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank (DB) Agrees to Pay $7.2B for Misleading Investors in Sale of RMBS
- Deutsche Bank Downgrades TCF Financial (TCB) to Hold
- TransDigm (TDG) Defended at Deutsche Bank
Create E-mail Alert Related CategoriesRumors, Trader Talk
Related EntitiesDeutsche Bank
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!